Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the
...Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., Angion Biomedica Corp., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________]... [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.01 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [140% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], the date on which the Registration Statement on Form S-1 (File No. 333-195261) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., Digital Power Corporation, a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [_________] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 November 1, [_______] (the "Expiration Date"), but not thereafter, to subsc
...ribe for, purchase and receive, in whole or in part, up to [●] [_________] shares of common stock of the Company, no par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[_______] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Taglich Brothers, Inc. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., Air Industries Group, a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE DATE OF THE COMMENCEMENT OF SALES OF THE OFFERING] (the "Commencement Date"), and
until at or before 5:00 p.m., Easte
...rn time, [●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE DATE OF THE COMMENCEMENT OF SALES OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [46,800] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[11.25] per Share; Share [125% OF THE OFFERING PRICE PER SHARE]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean the date of the commencement of sales by the Company pursuant to a prospectus supplement filed by the Company in connection with a registered direct offering of shares of common stock of the Company pursuant to a Registration Statement on Form S-3 (File No. 333-191748) of the Company that was declared effective by the Securities and Exchange Commission on December 11, 2013.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Eastside Distilling, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [date that is one year from the effective date of the offering] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [_________...___] [date that is four years from the Commencement Date] (the "Expiration Date"), but not thereafter, before the Commencement Date or after the Expiration Date, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [110% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [Roth Capital Partners, LLC/Feltl and Company, Inc.] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., The Joint Corp., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and
until at or before 5:00 p.m., Easter
...n time, [●], 2026 [_________] [DATE THAT IS FOUR YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the Effective Date and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[____] per Share; Share [125% of the price of the Company's common stock sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], the date on which the Registration Statement on Form S-1 (File No. 333-198860) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] EF Hutton, division of Benchmark Investments, LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon EPIEN Medical, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from
time to time beginning [●], 2022 [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 202...6 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] [120% OF THE PUBLIC OFFERING PRICE OF THE FIRM SHARES SOLD IN THE OFFERING] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [●], 2022, the date on which the Registration Statement on Form S-1 (File No. 333-[ ]) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid pursuant to that certain Underwriting Agreement by
or and between NAVA HEALTH MD, INC., a Maryland corporation (the "Company"), on
behalf of [●] ("Holder"), one hand, and THE WESTPARK CAPITAL, INC., on the other hand, dated [___], 2023 (as may be amended from time to time, the "Underwriting Agreement"), The WestPark Capital, Inc. ("Holder") and its assignees, as registered
owner holders of this Purchase Warrant,
to Tenon Medical, Inc., a D...elaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 from [____], 2023, the date that is six months following the effective date of the Company's Registration Statement on Form S-1 with the Securities and Exchange Commission (the "Commencement "Effective Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 on [___], 2028 (five (5) years from the Effective Date) (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [___] shares of common stock Common Stock of the Company, $0.01 par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. "Common Stock"). If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. purchase warrant ("Purchase Warrant"). This Purchase Warrant is initially exercisable at $[●] $[___] per Share; share of Common Stock (130% of the price of the Common Stock sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share share and the number of Shares shares of Common Stock to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, price as a result of the events set forth in Section 6 below, depending on the context. 1 A date that is five years after the Effective Date of this Warrant. 2 7.5% warrant coverage. 1 Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Spartan Capital Securities, LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Winc, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT] (the "Expirat
...ion Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____]1 shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [110% of the public offering price of the Initial Securities sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [_________], 2021, the date on which the Registration Statement on Form S-1 (File No. 333-259828) (the "IPO Registration Statement") of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] EF Hutton, division of Benchmark Investments, LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, American Rebel Holdings, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m.
..., Eastern time, [●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [__] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[__] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], 2022, the date on which the Registration Statement on Form S-1 (File No. 333-260646 ) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] EF Hutton, division of Benchmark Investments, LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, EMulate Therapeutics, Inc., a
Delaware Washington corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m
...., Eastern time, [●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [__] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[__] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], 2022, the date on which the Registration Statement on Form S-1 (File No. 333-[●]) of the Company was declared effective by the Securities and Exchange Commission.
View More
